Crestline Management’s Humana HUM Stock Holding History

Crestline Management’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,212	Closed	-$1.74M	–	149
2017 Q2	$1.74M	Buy	+7,212	New	+$1.63M	0.23%	49

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Crestline Management's HUM Position: Q3 2017 in Review

Crestline Management sold out of Humana (HUM) in Q3 2017, closing a stake of 7,212 shares — an estimated $1.74M sold.

Crestline Management first reported a position in HUM in Q2 2017 and held it in 1 quarter. The position peaked at $1.74M in Q2 2017. 655 funds tracked by Wall St. Rank hold HUM as of Q3 2017.

Crestline Management reported no remaining Humana position as of Q3 2017 after selling out during the quarter.
Crestline Management sold 7,212 Humana shares in Q3 2017, an estimated $1.74M.
Crestline Management first reported a position in Humana in Q2 2017 and held it in 1 quarter.
Crestline Management's Humana position peaked at $1.74M in Q2 2017.
655 funds tracked by Wall St. Rank held Humana as of Q3 2017.

Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.